ICP27 protein of Marek's disease virus interacts with SR proteins and inhibits the splicing of cellular telomerase chTERT and viral vIL8 transcripts

Journal of General Virology

Volumn 92, Issue 6, 2011, Pages 1273-1278

  Amor, S ^a   Strassheim, S ^a   Dambrine, G ^a,b   Remy, S ^b   Rasschaert, D ^a   Laurent, S ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ICP27 PROTEIN; INTERLEUKIN 8; MESSENGER RNA PRECURSOR; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHAHERPESVIRINAE; ARTICLE; BIRD DISEASE; HERPES VIRUS; LYMPHOMA; MAREK DISEASE; MAREK DISEASE VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL NUCLEUS; CHICKENS; DOWN-REGULATION; HERPESVIRUS 2, GALLID; INTERLEUKIN-8; MAREK DISEASE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN TRANSPORT; RNA SPLICING; SPLICEOSOMES; TELOMERASE; VIRAL PROTEINS;

AVES; GALLID HERPESVIRUS 2; HUMAN HERPESVIRUS 1;

EID: 79956310073     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.028969-0     Document Type: Article

References (28)

1. Akiyama, Y. & Kato, S. (1974). Two cell lines from lymphomas of Marek's disease. Biken J 17, 105-116.
2. Amor, S., Remy, S., Dambrine, G., Le Vern, Y., Rasschaert, D. & Laurent, S. (2010). Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo. BMC Cancer 10, 571.
3. Debba-Pavard, M., Ait-Lounis, A., Soubieux, D., Rasschaert, D. & Dambrine, G. (2008). Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens. Vaccine 26, 4904-4912.
4. Escudero-Paunetto, L., Li, L., Hernandez, F. P. & Sandri-Goldin, R. M. (2010). SR proteins SRp20 and 9G8 contribute to efficient export of herpes simplex virus 1 mRNAs. Virology 401, 155-164.
5. Hardwicke, M. A. & Sandri-Goldin, R. M. (1994). The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J Virol 68, 4797-4810.
6. Hardy, W. R. & Sandri-Goldin, R. M. (1994). Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol 68, 7790-7799.
7. Himly, M., Foster, D. N., Bottoli, I., Iacovoni, J. S. & Vogt, P. K. (1998). The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248, 295-304.
8. Laurent, S., Vautherot, J. F., Le Gall, G., Madelaine, M. F. & Rasschaert, D. (1997). Structural, antigenic and immunogenic relationships between European brown hare syndrome virus and rabbit haemorrhagic disease virus. J Gen Virol 78, 2803-2811.
9. Laurent, A. M., Madjar, J. J. & Greco, A. (1998). Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J Gen Virol 79, 2765-2775.
10. Long, J. C. & Caceres, J. F. (2009). The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417, 15-27.
11. Majerciak, V., Yamanegi, K., Allemand, E., Kruhlak, M., Krainer, A. R. & Zheng, Z. M. (2008). Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J Virol 82, 2792-2801.
12. Malik, P. & Schirmer, E. C. (2006). The Kaposi's sarcoma-associated herpesvirus ORF57 protein: a pleurotropic regulator of gene expression. Biochem Soc Trans 34, 705-710.
13. Mettenleiter, T. C., Klupp, B. G. & Granzow, H. (2009). Herpesvirus assembly: an update. Virus Res 143, 222-234.
14. Moriuchi, H., Moriuchi, M., Smith, H. A. & Cohen, J. I. (1994). Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol 68, 1987-1992.
15. Neugebauer, K. M., Stolk, J. A. & Roth, M. B. (1995). A conserved epitope on a subset of SR proteins defines a larger family of premRNA splicing factors. J Cell Biol 129, 899-908.
16. Nojima, T., Oshiro-Ideue, T., Nakanoya, H., Kawamura, H., Morimoto, T., Kawaguchi, Y., Kataoka, N. & Hagiwara, M. (2009). Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing. Nucleic Acids Res 37, 6515-6527.
17. Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K. & Trapp, S. (2006). Marek's disease virus: from miasma to model. Nat Rev Microbiol 4, 283-294.
18. Ote, I., Piette, J. & Sadzot-Delvaux, C. (2010). The varicella-zoster virus IE4 protein: a conserved member of the herpesviral mRNA export factors family and a potential alternative target in antiherpetic therapies. Biochem Pharmacol 80, 1973-1980.
19. Parcells, M. S., Lin, S. F., Dienglewicz, R. L., Majerciak, V., Robinson, D. R., Chen, H. C., Wu, Z., Dubyak, G. R., Brunovskis, P. & other authors (2001). Marek's disease virus (MDV) encodes an interleukin- 8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75, 5159-5173.
20. Petherbridge, L., Brown, A. C., Baigent, S. J., Howes, K., Sacco, M. A., Osterrieder, N. & Nair, V. K. (2004). Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78, 13376-13380.
21. Ren, D., Lee, L. F. & Coussens, P. M. (1994). Identification and characterization of Marek's disease virus genes homologous to ICP27 and glycoprotein K of herpes simplex virus-1. Virology 204, 242-250.
22. Ruvolo, V., Sun, L., Howard, K., Sung, S., Delecluse, H. J., Hammerschmidt, W. & Swaminathan, S. (2004). Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production. J Virol 78, 340-352.
23. Sandri-Goldin, R. M., Hibbard, M. K. & Hardwicke, M. A. (1995). The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however, these alterations are not sufficient to inhibit host cell splicing. J Virol 69, 6063-6076.
24. Sciabica, K. S., Dai, Q. J. & Sandri-Goldin, R. M. (2003). ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J 22, 1608-1619.
25. Shkreli, M., Dambrine, G., Soubieux, D., Kut, E. & Rasschaert, D. (2007). Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis. J Virol 81, 4848-4857.
26. Smith, R.W., Malik, P. & Clements, J. B. (2005). The herpes simplex virus ICP27 protein: a multifunctional post-transcriptional regulator of gene expression. Biochem Soc Trans 33, 499-501.
27. Stik, G., Laurent, S., Coupeau, D., Coutaud, B., Dambrine, G., Rasschaert, D. & Muylkens, B. (2010). A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs. RNA 16, 2263-2276.
28. Zhi, Y. & Sandri-Goldin, R. M. (1999). Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J Virol 73, 3246-3257.